Investment
Features
FeesSafety
Academy
More
Pluang+

Compare uniQure N.V. Ordinary Shares (QURE) vs Spotify Technology (SPOT) Price & Performance

uniQure N.V. Ordinary SharesTrade
Spotify TechnologyTrade

Price performance (Past 24H)

Key statistics

uniQure N.V. Ordinary Shares vs Spotify Technology — how do they compare? uniQure N.V. Ordinary Shares trades at $20.78 (market cap $1.48B), while Spotify Technology trades at $519.85 (market cap $108.44B). The key difference: Spotify Technology is far larger — about 73.3× uniQure N.V. Ordinary Shares's market cap, and Spotify Technology is trading nearer its 52-week high, uniQure N.V. Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold uniQure N.V. Ordinary Shares for 0 Days and Spotify Technology for 111 Days on average.

QURESPOT
Market Cap
$1.48B$108.44B
Volume
2,488,7801,252,448
Sector
HealthMedia
52-Week High
$70.59$689.21
52-Week Low
$9.03$412.75
Typical Hold Time
0 Days111 Days
Enterprise Value
$728.62M$98.48B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

uniQure N.V. Ordinary Shares

No Aura AI signal available yet.

Spotify Technology

Spotify (SPOT) trades at $523.96, down 0.92% on the day, as the stock consolidates near key technical support levels. The company demonstrates strong fundamental momentum with revenue growth accelerating to $17.19 billion in 2025 and net income surging to $2.21 billion, representing a 12.87% margin. Recent earnings show mixed results with Q2 2026 missing expectations, but analyst sentiment remains overwhelmingly positive with 62% buy ratings and a $588 consensus price target suggesting 12% upside potential.

The outlook remains favorable given Spotify's expanding gross margins and robust cash flow generation, though investors should monitor competitive pressures in streaming and potential market volatility. With technical indicators showing bullish moving average alignment and strong institutional support, the stock appears positioned for continued growth pending Q3 2026 earnings results expected October 22, 2026.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

QURE
100% Buy0% Sell
Avg holding period · 0 Days
SPOT
3% Buy97% Sell
Avg holding period · 111 Days

Top news

Latest headlines on both assets

About uniQure N.V. Ordinary Shares

uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.

Read more on QURE →

About Spotify Technology

Spotify Technology S.A. provides music streaming services. The Company offers commercial-free music and ad-supported services to subscribers. Spotify Technology serves clients worldwide.

Read more on SPOT →